Invega Trinza (paliperidone palmitate 3-month) Patient Assistance Program
Don’t let the high cost of brand every-3-month schizophrenia injection disrupt your mental health treatment. We help eligible patients access Invega Trinza (paliperidone palmitate 3-month long-acting IM) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
Key Takeaways:
- Invega Trinza (paliperidone palmitate 3-month) is FDA-approved for schizophrenia in adults adequately treated with Invega Sustenna (monthly) for at least 4 months. Every-3-month IM depot injection — extends the dosing interval from monthly to quarterly, dramatically reducing required medical contact for stable patients.
- Without assistance, Invega Trinza costs commonly run approximately $6,000–$8,000 per 3-month injection.
- Through AffordMyPrescriptions, qualifying patients can access Invega Trinza for a flat $69.95 per month.
- Related paliperidone LAIs (all brand): Invega Sustenna (monthly IM — starting LAI), Invega Hafyera (6-monthly IM — longest interval). Related long-acting antipsychotics: Abilify Maintena, Aristada, Risperdal Consta, Zyprexa Relprevv, Uzedy, Perseris. Oral antipsychotic generics widely available.
What is Invega Trinza Prescription Assistance Program?
The Invega Trinza Patient Assistance Program helps eligible patients access this every-3-month LAI at little or no cost when meeting income, insurance, and clinical criteria.
At AffordMyPrescriptions, our Patient Advocates handle the entire Invega Trinza PAP enrollment for a flat $69.95 per month — so you never face a gap in Invega Trinza therapy.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your Invega Trinza enrollment — so you never face a gap in your quarterly injectable schizophrenia therapy.
Pharmacy Price Comparison
- Without assistance, Invega Trinza costs thousands per quarterly injection. A Patient Assistance Program can offset costs if you qualify:
| PHARMACY | PRICE (30-DAY) WITH BEST COUPONS | YOU SAVE W/ US |
|---|---|---|
| Generic paliperidone oral | ~$50/mo | Cheap oral generic alt |
| Specialty pharmacy | ~$6,500/3-mo | Save substantially |
| Psychiatric clinic | ~$7,500/3-mo | Save substantially |
| Hospital pharmacy | ~$8,000/3-mo | Save substantially |
| 340B community mental health | ~$5,500/3-mo | Save substantially |
| Invega Sustenna (monthly LAI) | ~$1,800/mo | Related LAI monthly |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. AffordMyPrescriptions Advocacy Service bypasses pharmacy pricing entirely by using the manufacturer’s assistance program to secure your Invega Trinza — independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Invega Trinza Prescription Program?
The Invega Trinza Patient Assistance Program is free to apply. Our $69.95 per month covers full advocacy. Long-acting injectables improve adherence dramatically. Trinza reduces required medical contact to quarterly visits.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for Invega Trinza assistance.
We Advocate
Our specialists gather documentation, complete applications, and coordinate with your prescriber and the assistance program.
Receive Medication
Once approved, your Invega Trinza is delivered through the assistance program while we manage refills and annual renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Invega Trinza:
Limitations of Coupons
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $6,000–$8,000/3-mo even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
If denied, we explore alternative savings paths on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Invega Trinza assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Invega Trinza Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Invega Trinza:
Invega Trinza is the every-3-month IM injectable paliperidone palmitate — a bridge between monthly Sustenna and 6-monthly Hafyera. It requires prior stabilization on Invega Sustenna for at least 4 months.
How It Works:
Adherence to daily oral antipsychotics is challenging in schizophrenia — nonadherence drives relapse. Long-acting injectables ensure therapeutic drug levels for extended periods. Progressive interval extension from monthly to quarterly to twice-yearly reduces required medical contact for stable patients. Paliperidone palmitate is a depot IM formulation. Three formulations with different release characteristics: Invega Sustenna (monthly), Invega Trinza (3-monthly), Invega Hafyera (6-monthly) — the same paliperidone active drug, with different depot particle characteristics enabling different release durations.
Form and Use:
Invega Trinza IM injection in the deltoid or gluteal muscle every 3 months. Dose based on the Invega Sustenna monthly dose (typical conversion: multiply by 3.5). Requires prior stabilization on Sustenna for at least 4 months. Cold storage. Given at a psychiatric clinic.
Generic Availability:
No generic Invega Trinza. Related paliperidone LAIs: Invega Sustenna (monthly IM — starting formulation), Invega Hafyera (6-monthly IM — longest interval). Related LAIs (all brand): Abilify Maintena, Aristada, Risperdal Consta, Zyprexa Relprevv, Uzedy, Perseris. Oral antipsychotics: many generic. NAMI, community mental health centers.
Warnings:
Increased mortality in elderly patients with dementia-related psychosis (boxed warning), neuroleptic malignant syndrome, tardive dyskinesia, metabolic effects, hyperprolactinemia, orthostatic hypotension. Other: injection site reactions, sedation, akathisia, EPS. The long-acting nature means adverse effects may persist for months after the last dose.
FAQ (Frequently Asked Questions)
How much does Invega Trinza cost without insurance?
$6,000–$8,000 per quarterly injection (amortized ~$2,000–$2,700/month). Invega Sustenna monthly is $1,600–$2,000. Generic oral paliperidone is ~$50/month.
How is Invega Trinza different from Sustenna and Hafyera?
Same paliperidone palmitate — different intervals. Sustenna monthly (starting LAI). Trinza every 3 months (requires prior Sustenna stabilization for 4+ months). Hafyera every 6 months (requires prior stabilization). Progressive interval extension as the patient is stable.
Do I have to be stable on Invega Sustenna first?
Yes — Trinza requires stabilization on Sustenna for at least 4 consecutive monthly doses. This establishes tolerability and appropriate paliperidone response before extending the interval.
Why choose a long-acting injectable over oral?
Adherence — daily oral nonadherence drives relapse. Quarterly Trinza guarantees paliperidone levels between visits and eliminates daily pill-taking. Growing evidence shows LAIs improve outcomes vs oral.
What are common Invega Trinza side effects?
Standard atypical antipsychotic effects: weight gain, metabolic effects, hyperprolactinemia, sedation, akathisia, EPS. Injection site reactions. The long-acting formulation means effects may persist for months after the last dose.
Take Control of Your Medication Costs
Quarterly injectable schizophrenia therapy simplifies life and improves outcomes. Our advocacy team is ready — $69.95 per month, or free if we cannot help.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.